http://docs.noodls.com/viewDoc.asp?..._7B25B2858DB4DC2432F1A9428D5AA5C91D580062.PDF
• Phylogica and Genentech combine to search for new antibiotics to fight superbugs
• Genentech partnership was second biggest licence deal by any ASX listed biotech
in 2014
• Recent data confirms Phylogica’s cell penetrating peptides are ‘Best-in-Class’ for
delivering biologics drugs inside cells
• Phylogica uses its drug delivery solution to achieve unprecedented in vitro
potencies against MYC – one of the ‘holy grails’ of cancer targets
• Phylogica accelerating its proprietary Oncology discovery programme
PYC Price at posting:
4.8¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)